AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense

Trends in Immunology

Volumn 30, Issue 3, 2009, Pages 131-141

  Lai, Yuping ^a   Gallo, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT;

ANGIOGENESIS; ANTIGEN PRESENTATION; ANTIMICROBIAL ACTIVITY; CHEMOTAXIS; CYTOKINE RELEASE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; WOUND HEALING;

ANIMALS; BACTERIA; CATHELICIDINS; CHEMOTAXIS; CYTOKINES; DEFENSINS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; WOUND HEALING;

EID: 61349169039     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.12.003     Document Type: Review

References (116)

1. Braff M.H., and Gallo R.L. Antimicrobial peptides: an essential component of the skin defensive barrier. Curr. Top. Microbiol. Immunol. 306 (2006) 91-110
2. Wang Y., et al. Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS One 3 (2008) e3217
3. Zhao H., et al. Identification and characterization of novel reptile cathelicidins from elapid snakes. Peptides 29 (2008) 1685-1691
4. van Dijk A., et al. CMAP27, a novel chicken cathelicidin-like antimicrobial protein. Vet. Immunol. Immunopathol. 106 (2005) 321-327
5. Uzzell T., et al. Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides 24 (2003) 1655-1667
6. Zanetti M., et al. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374 (1995) 1-5
7. Sanchez J.F., et al. Overexpression and structural study of the cathelicidin motif of the protegrin-3 precursor. Biochemistry 41 (2002) 21-30
8. Storici P., et al. Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides. Eur. J. Biochem. 238 (1996) 769-776
9. Zaiou M., et al. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J. Invest. Dermatol. 120 (2003) 810-816
10. Sorensen O., et al. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J. Immunol. Methods 206 (1997) 53-59
11. Murakami M., et al. Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr. Res. 57 (2005) 10-15
12. Murakami M., et al. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172 (2004) 3070-3077
13. Bals R., et al. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9541-9546
14. Malm J., et al. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect. Immun. 68 (2000) 4297-4302
15. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75 (2004) 39-48
16. Cole A.M., et al. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97 (2001) 297-304
17. Yamasaki K., et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20 (2006) 2068-2080
18. Sorensen O., et al. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90 (1997) 2796-2803
19. Li X., et al. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J. Am. Chem. Soc. 128 (2006) 5776-5785
20. Braff M.H., et al. Cutaneous defense mechanisms by antimicrobial peptides. J. Invest. Dermatol. 125 (2005) 9-13
21. Zhu S. Did cathelicidins, a family of multifunctional host-defense peptides, arise from a cysteine protease inhibitor?. Trends Microbiol 16 (2008) 353-360
22. Duits L.A., et al. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 106 (2002) 517-525
23. Wilson C.L., et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286 (1999) 113-117
24. Yang D., et al. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22 (2004) 181-215
25. Menard S., et al. Developmental switch of intestinal antimicrobial peptide expression. J. Exp. Med. 205 (2008) 183-193
26. Li P., et al. An antimicrobial peptide gene found in the male reproductive system of rats. Science 291 (2001) 1783-1785
27. Zhou C.X., et al. An epididymis-specific beta-defensin is important for the initiation of sperm maturation. Nat. Cell Biol. 6 (2004) 458-464
28. Selsted M.E., and Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6 (2005) 551-557
29. Kida Y., et al. Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line, EBC-1. Mol. Immunol. 43 (2006) 1972-1981
30. Schauber J., et al. Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. Mol. Immunol. 41 (2004) 847-854
31. Wang T.T., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173 (2004) 2909-2912
32. Gombart A.F., et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19 (2005) 1067-1077
33. Weber G., et al. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol. 124 (2005) 1080-1082
34. Schauber J., et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J. Invest. Dermatol. 128 (2008) 816-824
35. Schauber J., et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117 (2007) 803-811
36. Liu P.T., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
37. Aberg K.M., et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J. Clin. Invest. 117 (2007) 3339-3349
38. Huang L.C., et al. In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid. Antimicrob. Agents Chemother. 51 (2007) 3853-3860
39. Lehrer R.I., and Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11 (1999) 23-27
40. Nizet V., et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414 (2001) 454-457
41. Lee P.H., et al. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3750-3755
42. Howell M.D., et al. Cathelicidin deficiency predisposes to eczema herpeticum. J. Allergy Clin. Immunol. 117 (2006) 836-841
43. Chromek M., et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12 (2006) 636-641
44. Howell M.D., et al. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J. Immunol. 172 (2004) 1763-1767
45. Moser C., et al. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70 (2002) 3068-3072
46. Morrison G., et al. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect. Immun. 70 (2002) 3053-3060
47. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3 (2005) 238-250
48. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462 (1999) 55-70
49. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
50. Nakajima Y., et al. Interaction between liposomes and sarcotoxin IA, a potent antibacterial protein of Sarcophaga peregrina (flesh fly). J. Biol. Chem. 262 (1987) 1665-1669
51. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462 (1999) 1-10
52. Sorensen O., et al. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J. Biol. Chem. 274 (1999) 22445-22451
53. Maisetta G., et al. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 29 (2008) 1-6
54. Dorschner R.A., et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 20 (2006) 35-42
55. Johansson J., et al. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273 (1998) 3718-3724
56. Bullard R.S., et al. Functional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancer. Mol. Immunol. 45 (2008) 839-848
57. Coffelt S.B., and Scandurro A.B. Tumors sound the alarmin(s). Cancer Res. 68 (2008) 6482-6485
58. Sun C.Q., et al. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res. 66 (2006) 8542-8549
59. Kai-Larsen Y., and Agerberth B. The role of the multifunctional peptide LL-37 in host defense. Front. Biosci. 13 (2008) 3760-3767
60. Dorschner R.A., et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117 (2001) 91-97
61. Territo M.C., et al. Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Invest. 84 (1989) 2017-2020
62. Yang D., et al. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23 (2002) 291-296
63. Niyonsaba F., et al. Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int. Immunol. 14 (2002) 421-426
64. Yang D., et al. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 69 (2001) 691-697
65. Yang D., et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525-528
66. Wu Z., et al. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8880-8885
67. Taylor K., et al. Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. J. Biol. Chem. 283 (2008) 6631-6639
68. Soruri A., et al. beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur. J. Immunol. 37 (2007) 2474-2486
69. Yang D., et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192 (2000) 1069-1074
70. Kurosaka K., et al. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174 (2005) 6257-6265
71. Elssner A., et al. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 172 (2004) 4987-4994
72. Yu J., et al. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J. Immunol. 179 (2007) 7684-7691
73. Funderburg N., et al. Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 18631-18635
74. Niyonsaba F., et al. The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J. Immunol. 175 (2005) 1776-1784
75. Niyonsaba F., et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127 (2007) 594-604
76. Yoshimoto T., et al. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat. Immunol. 1 (2000) 132-137
77. Nakanishi K., et al. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19 (2001) 423-474
78. Di Nardo A., et al. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J. Immunol. 178 (2007) 1829-1834
79. Morioka Y., et al. Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis. J. Immunol. 181 (2008) 3915-3922
80. Mookherjee N., et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176 (2006) 2455-2464
81. Mookherjee N., et al. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J. Leukoc. Biol. 80 (2006) 1563-1574
82. Tydell C.C., et al. Bovine peptidoglycan recognition protein-S: antimicrobial activity, localization, secretion, and binding properties. J. Immunol. 176 (2006) 1154-1162
83. Yibin G., et al. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro. Biochem. Pharmacol. 70 (2005) 209-219
84. Rosenfeld Y., et al. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 281 (2006) 1636-1643
85. Chen X., et al. Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins. J. Med. Chem. 49 (2006) 7754-7765
86. Heilborn J.D., et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120 (2003) 379-389
87. Baroni A., et al. Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells. Peptides 32 (2009) 267-272
88. Gallo R.L., et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 11035-11039
89. Tokumaru S., et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J. Immunol. 175 (2005) 4662-4668
90. Carretero M., et al. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J. Invest. Dermatol. 128 (2008) 223-236
91. Koczulla R., et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111 (2003) 1665-1672
92. Park, H. J. et al. (2008) Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37. J. Invest. Dermatol. DOI: 10.1038/jid.2008.320 (in press)
93. Ong P.Y., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347 (2002) 1151-1160
94. Fellermann K., et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 79 (2006) 439-448
95. Linzmeier R.M., and Ganz T. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics 86 (2005) 423-430
96. Yamasaki K., et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13 (2007) 975-980
97. Lande R., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449 (2007) 564-569
98. Ma H.L., et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118 (2008) 597-607
99. Wilson N.J., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8 (2007) 950-957
100. Islam D., et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7 (2001) 180-185
101. Sieprawska-Lupa M., et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48 (2004) 4673-4679
102. Lai Y., et al. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol. 63 (2007) 497-506
103. Peschel A., et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 193 (2001) 1067-1076
104. Li M., et al. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol. 66 (2007) 1136-1147
105. Li M., et al. Gram-positive three-component antimicrobial peptide-sensing system. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 9469-9474
106. Gunn J.S., et al. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect. Immun. 68 (2000) 6139-6146
107. Weidenmaier C., and Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 6 (2008) 276-287
108. Kristian S.A., et al. D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 187 (2005) 6719-6725
109. Bader M.W., et al. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122 (2005) 461-472
110. Marta Guarna M., et al. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris. FEMS Microbiol. Lett. 257 (2006) 1-6
111. Frohm M., et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272 (1997) 15258-15263
112. Fahlgren A., et al. beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin. Exp. Immunol. 137 (2004) 379-385
113. Wehkamp J., et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 9 (2003) 215-223
114. Boman H.G. Innate immunity and the normal microflora. Immunol. Rev. 173 (2000) 5-16
115. Ghosh D., et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3 (2002) 583-590
116. Diamond G., et al. Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect. Immun. 68 (2000) 113-119